Hello, danabethb-ga!
There is very little statistical information concerning insulin pump
usage and market share available in the public domain - unless you are
willing to pay a hefty price! I was able to find some tidbits of
relevant information after many hours of searching, but if you need
very comprehensive statistics about the insulin pump market, you might
need to go the way of a market research report.
The following 2005 market report, titled "Diabetes, Metabolic Syndrome
& Cardiovascular Disease: Reshaping Tomorrow's Diabetes Market,"
contains several sections on insulan pumps and is available $3,200!
http://www.leaddiscovery.co.uk/reports/Diabetes,%20Metabolic%20Syndrome%20&%20Cardiovascular%20Disease%20-%20Reshaping%20Tomorrow's%20Diabetes%20Market.html
"Diabetes Monitoring Products & Therapies to 2008" also contains some
comprehensive market information on insulin pumps and sells for
approximately: $4,044!
http://www.piribo.com/publications/diseases_conditions/diabetes/FED007.html
In lieu of paying out such a considerable sum, I have compiled some
information that should be helpful.
Worldwide
==========
There are approximately 400,000 insulin pump users worldwide
"The annual worldwide market for conventional insulin pump products is
approximately £1.5 billion. There are an estimated 400,000 insulin
pump users and their number is growing by 12 - 14% per annum."
See "New generation of insulin pump - Starbridge secures global
diabetes contract." Medical News Today. 19 Nov 2005
http://www.medicalnewstoday.com/medicalnews.php?newsid=33847
United States
===============
There are approximately 200,000 insulin pump users in the United States.
Approximately 10,000 of these users have Type 2 Diabetes.
"An estimated 200,000 people in the United States use insulin pumps
today, and about 10,000 of those are believed to have Type 2 diabetes.
Surprised? Type 2 diabetes is a progressive disease that causes many
people who have it to eventually need to use insulin to control their
blood glucose levels. Although many people still think insulin pumps
are only for treatment of Type 1 diabetes, they can also be useful for
some people with Type 2 diabetes.
See "Insulin Pumps Not Just for Type 1," by Jan Chait. Diabetes Self
Management. Published in the January/February 2005 issue
http://www.diabetesselfmanagement.com/article.cfm?sid=2&tid=42&aid=1844&sk=9AAH
=
Animas Corporation estimates a slightly higher number:
"The company estimates about 250,000 people in the United States use
insulin pumps, and the estimated domestic market potential is more
than a million potential users."
See "Deal pumps up insiders," by John George. January 23, 2006
http://philadelphia.bizjournals.com/bizwomen/philadelphia/content/story.html?story_id=1217256
==
Some older statistics follow:
From a 2003 article:
"It has been estimated that 0.19per cent of people with Type 1
diabetes in the UK use pumps (650) compared with about 8per cent in
the United States, 12 per cent in Sweden, and 10per cent in
Germany[1]. This would appear to indicate that this treatment is
under-utilised in the UK."
http://www.diabetes.org.uk/infocentre/state/pump.htm
More 2003 UK statistics:
"DiabetesUK estimates that approximately one fifth of one per cent of
people with Type 1 diabetes in the UK use pumps (that is one I five
hundred people with type 1 diabetes). The total numbers across the UK
are likely to be under one thousand. This compares with about eight
per cent in the United States, 12 per cent in Sweden, and 10 per cent
in Germany."1
http://www.diabetesuffolk.com/Managing%20Diabetes/Insulin%20pump%20therapy.asp
2003 statistics for Germany:
"Across all ages there are currently 20,000 pumps in use in Germany
and 100,000 in the United States.3 At present the major centres in
the UK (for example, Bournemouth and Harrogate) cater for a largely
adult population, with small numbers of children and young people
using insulin pumps.*
From "Insulin pumps," by T Torrance, V Franklin and S Greene. Archives
of Disease in Childhood 2003; 88:949-953
http://adc.bmjjournals.com/cgi/content/full/88/11/949
2002 numbers were considerably less:
"Currently, over 180,000 individuals with diabetes worldwide wear
portable insulin pumps, and this number has been increasing each year.
Most pump users have Type 1 diabetes, but some people with Type 2
diabetes who require insulin are choosing to pump insulin as well.
See "Exercising With an Insulin Pump," by Sheri Colberg, Ph.D.
Diabetes Self Management. Published in the January/February 2002
issue.
http://www.diabetesselfmanagement.com/article.cfm?aid=1212&sid=9
More 2002 statistics:
"A quarter of a century after its introduction, CSII is widely used in
clinical practice; there are now estimated (largely from pump sales)
to be >200,000 diabetic subjects worldwide using CSII for their
everyday treatment, with >130,000 in the U.S. alone [16]. However,
there are major variations in usage: in some countries, such as the
U.K., there are only a few hundred pump users but growing pressure
from diabetic patients to increase its availability."
See "Continuous Subcutaneous Insulin Infusion at 25 Years: Evidence
Base for the Expanding Use of Insulin Pump Therapy in Type 1
Diabetes." Diabetes Care 25(3):593-598, 2002
http://www.medscape.com/viewarticle/429762
Some statistics from 1999 - 2001:
"From 1990-2001, the usage of insulin pumps increased exponentially
from almost 9,000 to over 160,000."
See 2004 Conference Proceedings
http://www.csun.edu/cod/conf/2004/proceedings/54.htm
"In a study published in The Diabetes Educator, 60% of the members of
the American Association of Diabetes Educators (AADE) and 52% of
American Diabetes Association (ADA) professionals with type 1 diabetes
said that they use an insulin pump."
http://www.disetronic-usa.com/introductiontoinsulinpumptherapy_3.htm
Industry Overview
==================
A very good report concerning the Medtronic Minimed contains some
valuable industry information. I have included some excerpts below:
"The insulin pump market includes both a durable good and a
consumables component. The pump itself sells for about $5,000 and
lasts for 5 years; consumables cost the user about $6 per day.
Currently, the vast majority of the insulin-injecting market still
uses substitute products with a longer history in the market (syringes
or insulin pens). Only about 10% of Type I diabetics (~100,000 people)
use infusion pumps, and almost no Type II diabetics use them.5 This is
changing as people start to better understand the benefits of tight
insulin control, and gain comfort and familiarity with being connected
to an insulin pump 24 hours per day (Figure 1, below). Growth rate in
the insulin pump industry is about 9% per year, compared to about 2%
in the overall diabetic population."6
See "MedtronicMiniMed in the Insulin Pump Industry." May 11, 2005
http://ocw.mit.edu/NR/rdonlyres/Sloan-School-of-Management/15-912Spring-2005/68CA6D9B-B4B4-45D6-9E2A-9FC7EF1B4A56/0/insulin_pu_indry.pdf
==
From a 2002 publication:
"The actual clinical use of insulin pumps in the United States is
poorly understood. Approximately 162,000 people are registered with
the major manufacturers. However, there are no data regarding how many
of these patients are still actively using their pumps."
"There is a vague notion that most people who purchase insulin pumps
are Caucasian, relatively better-educated, and more affluent than the
overall population of Americans with diabetes. Health care
professionals who have diabetes seem to prefer CSII therapy over other
forms of insulin delivery for their own treatment." 6
"Medtronic Minimed pumps dominate the market in the United States,
whereas Disetronic pumps are predominant in other countries. Although
the insulin pump market has slowed recently, total sales of pumps and
related supplies are now thought to exceed $1 billion per year. " 7-9
From "The Business of Insulin Pumps in Diabetes Care: Clinical and
Economic Considerations," by Soraya Jane Kanakis, PharmD, Carolyn
Watts, PhD and Steven B. Leichter, MD, FACP, FACE. Clinical Diabetes
20:214-216, 2002
http://scholar.google.com/scholar?q=insulin+pump+sales&ie=UTF-8&oe=UTF-8&hl=en
==
The following excerpt is from a 2003 publication
"Over the past two decades I have watched more than 30 insulin pump
companies come and go, most of which were located in the US. When
AutoSyringe introduced one of the first commercial pumps in 1978,
great excitement spread throughout the medical device industry, with
visions of several million insulin-using patients as potential
customers. Large companies, small companies and start-ups all jumped
at what they thought to be an easy opportunity. At diabetes meetings,
AutoSyringe reported early sales exceeding 600 pumps per month, which,
in the rumour mill of the time, confirmed everyone?s conviction that
the total market potential was huge. Was insulin pump therapy really
this good, and the opportunity really that big? If so, why did so few
companies survive?
"The opportunity foreseen in the 1980s was indeed real - it just took
10 to 15 years longer than many expected. Growth in the pump market
today is a remarkable 50% per year."
"If the opportunity truly is this large, why are there only two
players in the US market today: Medtronic MiniMed, Inc., a US company
based in Los Angeles, with approximately 85% market share and
Disetronic Medical Systems AG, a Swiss company with US distribution
offices in Minneapolis, having the balance of approximately 15% market
share. A new start-up, the Animas Corporation, launched their first
product on 1 July 2001."
Read further....
See "Insulin Pumps - Evolution of an Industry," by Cliff Hague.
Business Briefing: European Pharmacotherapy. 2003
http://www.touchbriefings.com/pdf/27/ept031_t_Medtro~2.pdf
==
"Both insulin jet injectors and insulin pumps have been around for
several years but haven't managed to capture a significant amount of
interest within the market, partly because they require regular
cleaning and maintenance and can be very expensive compared with
traditional injectable devices. Due to this, the next generation of
non-injectable insulin devices may prove a particular challenge for
these sectors."
From "Insulin delivery devices - an industry under threat," by Kirsty
Barnes. InPharma Technologis. 17/02/2006
http://www.in-pharmatechnologist.com/news/ng.asp?n=65898-nektar-therapeutics-novo-nordisk-insulin-device-non-injectable-insulin
==
From a 2005 Newsletter:
"With regard to insulin pumps, Medtronic is currently the market
leader. Given the explosion in the number of patients, it is estimated
that the diabetes drug market (insulin products and antidiabetic
agents) will represent about $20 billion by 2007 while the market for
insulin delivery and monitoring devices will be worth some $10 billion
(1)."
See "The insulin market."
http://www.parisdeveloppement.com/index.php?id=993212622&langue=2
==
From a 2003 Medtronic article:
"Even though scientific evidence clearly supports the immediate and
long-term benefits of insulin pump therapy over conventional use of
insulin shots, less than 20% of insulin dependent people in the U.S.
currently use an insulin pump. However, according to a large survey
published in Diabetes Educator, over 60% of the physicians and nurses
who are involved in treating diabetes, and who have Type 1 diabetes
themselves, also use an insulin pump. So you can see that we have a
significant opportunity and patient education effort in front of us."
See "Creating a Blueprint for Sustained Growth," by Art Collins,
Chairman and CEO, Medtronic. Annual Investors Conference - 2003 Annual
Meeting. Minneapolis, MN Sep 30, 2003
http://wwwp.medtronic.com/Newsroom/Speech.do?itemId=1100640695909&lang=en_US
==
From the Medtronics website:
"Pump technology started in the late 1960s with a pump the size of a
backpack produced by American Dr Arnold Kadish. The sheer size of the
Kadish device made it impractical. In the 1980s dozens of companies
tried to create an effective insulin pump, yet many failed. Today, one
company has been serving customers continuously for more than 20 years
- Medtronic Diabetes. This company has led the industry with new
insulin pump features and is leading the development of an artificial
pancreas.
"In Australia, around 2000 patients have converted from injections to
pump therapy and, worldwide, 350,000 are estimated to use this
important therapy. Patients, including children with diabetes, and
their clinicians, are rapidly recognising the advantages of insulin
pump therapy."
"Many recent studies have shown that pumps are both safe and effective
for toddlers and young children, so long as the parents are highly
motivated. "We?ve got about 50 kids on pumps (in our clinic), and a
very long waiting list," says Dr Cameron."
"Medtronic Diabetes is also testing implantable insulin pumps in
clinical trials. "More than 350 people are using implantable pumps
under clinical protocol today. With this system, insulin is refilled
on average every 90 days," says Mr Gurgulino. "Medtronic also expects
to create a fully implantable artificial pancreas using this
technology and its implantable glucose sensor, but this program is
much further in the future."
See "Towards a Cure."
http://www.minimed.com.au/diabetes-bulletin.php
Sales by Manufacturer
=====================
I was only able to find scattered and very general information. You
might be able to find detailed numbers for sales by product for each
company by registering on the Hoovers website.
See Annual sales of top competitors to Minimed from Hoovers:
Animas Novo Nordisk PolyMedica
Annual Sales 67.9 5,327.0 451.5
Market Cap ($ mil.) 508.4 18, 734.6 961.6
See http://www.hoovers.com/medtronic-minimed/--ID__44066,ticker__--/free-co-fin-factsheet.xhtml
==
Take a look at the relevant pages from Hoovers and determine if you
would like to register:
Medtronic Minimed
http://www.hoovers.com/medtronic-minimed/--ID__44066--/free-co-factsheet.xhtml
Animas Corporation
http://www.hoovers.com/animas/--ID__132465--/free-co-factsheet.xhtml
==
Minimed implantable pump:
"The MiniMed 2001 Implantable Insulin Pump is a key component to
MiniMed's ultimate goal: the creation of a true artificial pancreas.
The pump has received the CE mark for approval of sales in the
European market, but commercialization is limited pending approval of
the special insulin used in the pump.
* Over 600 of the devices have been implanted worldwide."
See http://www.diabetic.com/MiniMed.htm
==
2005 figures from Roche:
" The new Accu-Chek Spirit insulin pump is now available in 21
countries and accounts for 40% of all Roche insulin pump sales."
See "Roche continues to post strong growth through third quarter." October 2005
http://www.roche.com/med-cor-2005-10-19
==
2003 figures from Disetronic:
Disetronic - "Headquartered in Burgdorf near Berne, Switzerland,
Disetronic has been a world leader in the research and development of
insulin pumps and injection systems for the treatment of diabetes
since 1984. Its two core businesses generated combined sales of 240.1
million Swiss francs in the first nine months of the 2002/2003
business year (April to December 2002), representing a year-on-year
increase of 14.3% in local currencies."
See "Roche expands position in diabetes market - Public tender offer
to Disetronic shareholders." http://www.roche.com/med-cor-2003-02-10b
==
Deltec Cozmore pump:
"We have sold over 150,000 pumps worldwide. We enjoy a strong
position in the hospital market. And we are the market leader in pumps
for home health care."
See Cozmore website: http://www.cozmore.com/default.cfm/PID=1.11
Pump Preferences among users
=============================
While not very scientific, InsulinPumpers.org has compiled some
interesting graphs concerning the pump preferences of their members.
Scroll down the the graphs under List Member Composition.
http://www.insulin-pumpers.org/about.shtml
Insulin Pumps pose problems for many users
===========================================
See "Inhalable Insulin to ameliorate pump problems," by Lindsay
Pieper. Collegiate Times. February 1st, 2006
http://www.collegiatetimes.com/news/1/ARTICLE/6386/2006-02-01.html?sid=a03a519e9330432612ee5a1e36eccf06
Additional
===========
If you have access to the Diabetes Educator, you might be interested
in the following article:
"Treating the Spectrum of Type 2 Diabetes: Emphasis on Insulin Pump Therapy
Steven D. Wittlin. The Diabetes Educator, Vol. 32, No. 1, 39S-46S (2006)
http://tde.sagepub.com/cgi/content/citation/32/1/39S
==
Again - I hope the information I have provided is helpful!
Sincerely,
umiat
Search Strategy
insulin pumps
insulin pump usage OR use
Type 2 diabetes AND insulin pump
sales of insulin pumps worldwide
insulin pump users United States
insulin pump sales statistics
insulin pump sales by company
insulin pump sales worldwide
thousand use insulin pump
future market for insulin pumps
insulin pump projections
minimed pump sales
medtronic insulin pump
Animas Corporation 2005 sales
Deltec insulin pump |
